155 related articles for article (PubMed ID: 32164367)
1. Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo.
Mandro M; Siewe Fodjo JN; Dusabimana A; Mukendi D; Haesendonckx S; Lokonda R; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Hotterbeekx A; Abrams S; Colebunders R
Pathogens; 2020 Mar; 9(3):. PubMed ID: 32164367
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
Mandro M; Siewe Fodjo JN; Mukendi D; Dusabimana A; Menon S; Haesendonckx S; Lokonda R; Nakato S; Nyisi F; Abhafule G; Wonya'Rossi D; Jakwong JM; Suykerbuyk P; Meganck J; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007966. PubMed ID: 31923177
[TBL] [Abstract][Full Text] [Related]
3. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
4. Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with
Dusabimana A; Tsebeni Wafula S; Raimon SJ; Fodjo JNS; Bhwana D; Tepage F; Abd-Elfarag G; Hotterbeekx A; Abrams S; Colebunders R
Pathogens; 2020 Dec; 10(1):. PubMed ID: 33396221
[TBL] [Abstract][Full Text] [Related]
5. Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial.
Colebunders R; Mandro M; Mukendi D; Dolo H; Suykerbuyk P; Van Oijen M
JMIR Res Protoc; 2017 Aug; 6(8):e137. PubMed ID: 28855148
[TBL] [Abstract][Full Text] [Related]
6. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D; Tepage F; Akonda I; Siewe JNF; Rotsaert A; Ndibmun CN; Laudisoit A; Couvreur S; Kabutako B; Menon S; Hotterbeekx A; Colebunders R
Int J Infect Dis; 2019 Feb; 79():187-194. PubMed ID: 30711145
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
[TBL] [Abstract][Full Text] [Related]
9. Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.
Bhwana D; Mmbando BP; Dusabimana A; Mhina A; Challe DP; Fodjo JNS; Makunde WH; Colebunders R
Afr Health Sci; 2022 Sep; 22(3):607-616. PubMed ID: 36910370
[TBL] [Abstract][Full Text] [Related]
10. Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection.
Abd-Elfarag G; Carter JY; Raimon S; Sebit W; Suliman A; Fodjo JNS; Olore PC; Biel KP; Ojok M; Logora MY; Colebunders R
Epileptic Disord; 2020 Jun; 22(3):301-308. PubMed ID: 32540799
[TBL] [Abstract][Full Text] [Related]
11. Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.
Mandro M; Suykerbuyk P; Tepage F; Rossy D; Ngave F; Hasan MN; Hotterbeekx A; Mambandu G; Kashama JM; Laudisoit A; Colebunders R
Infect Dis Poverty; 2018 Oct; 7(1):79. PubMed ID: 30293530
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study.
Dusabimana A; Bhwana D; Raimon S; Mmbando BP; Hotterbeekx A; Tepage F; Mandro M; Siewe Fodjo JN; Abrams S; Colebunders R
Pathogens; 2020 Jul; 9(8):. PubMed ID: 32751060
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.
Lenaerts E; Mandro M; Mukendi D; Suykerbuyk P; Dolo H; Wonya'Rossi D; Ngave F; Ensoy-Musoro C; Laudisoit A; Hotterbeekx A; Colebunders R
Infect Dis Poverty; 2018 Aug; 7(1):68. PubMed ID: 30064504
[TBL] [Abstract][Full Text] [Related]
14. Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic.
Druet-Cabanac M; Preux PM; Bouteille B; Bernet-Bernady P; Dunand J; Hopkins A; Yaya G; Tabo A; Sartoris C; Macharia W; Dumas M
Am J Epidemiol; 1999 Mar; 149(6):565-70. PubMed ID: 10084246
[TBL] [Abstract][Full Text] [Related]
15. Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.
Bakajika D; Kanza EM; Opoku NO; Howard HM; Mambandu GL; Nyathirombo A; Nigo MM; Kennedy KK; Masembe SL; Mumbere M; Kataliko K; Bolay KM; Attah SK; Olipoh G; Asare S; Vaillant M; Halleux CM; Kuesel AC
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010079. PubMed ID: 35476631
[TBL] [Abstract][Full Text] [Related]
16. OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study.
Dusabimana A; Bhwana D; Mandro M; Mmbando BP; Siewe Fodjo JN; Colebunders R
Pathogens; 2020 Oct; 9(10):. PubMed ID: 33081184
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
18. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
19. Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis
Hotterbeekx A; Dusabimana A; Mandro M; Abhafule GM; Deogratias W; Siewe Fodjo JN; Abrams S; Colebunders R
Pathogens; 2020 Mar; 9(3):. PubMed ID: 32151038
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania.
Bhwana D; Mmbando BP; Dekker MC; Mnacho M; Kakorozya A; Matuja W; Makunde WH; Weckhuysen S; Colebunders R
Epileptic Disord; 2019 Oct; 21(5):425-435. PubMed ID: 31649005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
